Clinical Trial Update: The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial [NA]

View source ↗

Summary

A multicenter randomized trial compares different doses of atropine for slowing myopic progression in highly myopic children. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: Shanghai Eye Disease Prevention and Treatment Center | Conditions: High Myopia | NA | Status: COMPLETED